MBX Microbix Biosystems | C$0.31
+3.3% | 6/5/2025 | Downgraded by | Bloom Burton | Analyst D. Martin | Strong-Buy -> Moderate Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/5/2025 |
RPTX Repare Therapeutics | $1.42
-1.4% | 1/10/2025 | Downgraded by | Bloom Burton | Analyst D. Martin | Strong-Buy -> Hold | | Medium | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 1/10/2025 |
CYBN Cybin | $7.87
-0.9% | 5/2/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Cybin (OTCMKTS:CYBN) on 5/2/2024 |
RPTX Repare Therapeutics | $1.42
-1.4% | 4/19/2024 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 4/19/2024 |
RPTX Repare Therapeutics | $1.42
-1.4% | 2/13/2024 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 2/13/2024 |
MBX Microbix Biosystems | C$0.31
+3.3% | 1/4/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024 |
ABCL AbCellera Biologics | $4.03
+6.1% | 11/3/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023 |
MDP Medexus Pharmaceuticals | C$3.01
-3.2% | 6/26/2023 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023 |
RX BioSyent | C$11.90
-0.7% | 3/23/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023 |
DOC CloudMD Software & Services | C$0.04
| 11/16/2022 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
DOC CloudMD Software & Services | C$0.04
| 8/24/2022 | Downgraded by | Bloom Burton | Analyst P. Pandurangan | Buy -> Hold | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022 |
MDNA Medicenna Therapeutics | C$0.86
-5.5% | 8/16/2022 | Target Lowered by | Bloom Burton | - | Buy | C$9.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022 |
MDNA Medicenna Therapeutics | C$0.86
-5.5% | 7/28/2022 | Reiterated by | Bloom Burton | - | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022 |
HLS HLS Therapeutics | C$4.88
-1.2% | 7/26/2022 | Reiterated by | Bloom Burton | - | Buy | C$22.00 | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022 |
MBX Microbix Biosystems | C$0.31
+3.3% | 6/6/2022 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022 |
GUD Knight Therapeutics | C$6.04
-0.2% | 3/28/2022 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | C$6.70 | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022 |
GUD Knight Therapeutics | C$6.04
-0.2% | 3/25/2022 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022 |
RX BioSyent | C$11.90
-0.7% | 3/10/2022 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022 |
DOC CloudMD Software & Services | C$0.04
| 12/22/2021 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Buy | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021 |
ABCL AbCellera Biologics | $4.03
+6.1% | 12/19/2021 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021 |
AUPH Aurinia Pharmaceuticals | $7.47
-1.6% | 10/1/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Hold | $23.00 | Medium | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021 |
RPTX Repare Therapeutics | $1.42
-1.4% | 9/30/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | $49.00 | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/30/2021 |
MDNA Medicenna Therapeutics | C$0.86
-5.5% | 9/22/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021 |
HLS HLS Therapeutics | C$4.88
-1.2% | 8/5/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021 |
VMD Viemed Healthcare | $6.87
-3.9% | 8/4/2021 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021 |
AUPH Aurinia Pharmaceuticals | $7.47
-1.6% | 5/7/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | High | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021 |
GUD Knight Therapeutics | C$6.04
-0.2% | 3/26/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021 |
RX BioSyent | C$11.90
-0.7% | 3/18/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021 |
MDP Medexus Pharmaceuticals | C$3.01
-3.2% | 2/23/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 2/23/2021 |
EPIX ESSA Pharma | $1.70
-2.3% | 2/12/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 2/12/2021 |
CRHM CRH Medical | $3.99
| 1/8/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Hold | $3.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 1/8/2021 |
CRHM CRH Medical | $3.99
| 12/23/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 12/23/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020 |
AUPH Aurinia Pharmaceuticals | $7.47
-1.6% | 11/3/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020 |
VMD Viemed Healthcare | $6.87
-3.9% | 10/19/2020 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Accumulate | | High | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020 |
RPTX Repare Therapeutics | $1.42
-1.4% | 9/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/17/2020 |
HTL Hamilton Thorne | C$1.45
+4.3% | 8/21/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020 |
XENE Xenon Pharmaceuticals | $31.83
-4.3% | 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $25.00 | Medium | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020 |
CRH CRH | $94.33
-0.6% | 8/14/2020 | Reiterated by | Bloom Burton | - | Buy | | Low | View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020 |
CRHM CRH Medical | $3.99
| 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $4.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/13/2020 |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
CRHM CRH Medical | $3.99
| 8/12/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/12/2020 |
HLS HLS Therapeutics | C$4.88
-1.2% | 7/21/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020 |
GUD Knight Therapeutics | C$6.04
-0.2% | 6/29/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020 |
ZYME Zymeworks | $13.08
+0.3% | 6/14/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Zymeworks (NYSE:ZYME) on 6/14/2020 |
EPIX ESSA Pharma | $1.70
-2.3% | 5/24/2020 | Reiterated by | Bloom Burton | - | Buy | $9.00 | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/24/2020 |
CPH Cipher Pharmaceuticals | C$13.29
-2.1% | 5/8/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020 |
HLS HLS Therapeutics | C$4.88
-1.2% | 3/31/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020 |
RX BioSyent | C$11.90
-0.7% | 3/19/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020 |
AUPH Aurinia Pharmaceuticals | $7.47
-1.6% | 3/19/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $23.00 | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/12/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019 |
GUD Knight Therapeutics | C$6.04
-0.2% | 10/22/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019 |
HLS HLS Therapeutics | C$4.88
-1.2% | 10/4/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019 |
AUPH Aurinia Pharmaceuticals | $7.47
-1.6% | 10/2/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019 |
RX BioSyent | C$11.90
-0.7% | 8/26/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019 |
CPH Cipher Pharmaceuticals | C$13.29
-2.1% | 8/12/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019 |
HLS HLS Therapeutics | C$4.88
-1.2% | 8/9/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019 |
CRHM CRH Medical | $3.99
| 8/1/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/1/2019 |
MDP Medexus Pharmaceuticals | C$3.01
-3.2% | 7/3/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 7/3/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/16/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 4/1/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019 |
HLS HLS Therapeutics | C$4.88
-1.2% | 3/22/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019 |
CPH Cipher Pharmaceuticals | C$13.29
-2.1% | 3/20/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019 |
CXRXF ADVANZ PHARMA | $17.06
| 3/15/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | Low | View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019 |
GUD Knight Therapeutics | C$6.04
-0.2% | 11/9/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 3/26/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018 |
RX BioSyent | C$11.90
-0.7% | 3/22/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018 |
EPI ESSA Pharma | C$8.20
+7.2% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018 |
EPIX ESSA Pharma | $1.70
-2.3% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 1/18/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/3/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017 |
HTL Hamilton Thorne | C$1.45
+4.3% | 10/25/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017 |
EPIX ESSA Pharma | $1.70
-2.3% | 9/12/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 9/12/2017 |
CPH Cipher Pharmaceuticals | C$13.29
-2.1% | 8/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017 |
CRHM CRH Medical | $3.99
| 7/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 7/14/2017 |
EPIX ESSA Pharma | $1.70
-2.3% | 5/18/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/18/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/15/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017 |
CPH Cipher Pharmaceuticals | C$13.29
-2.1% | 5/12/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/9/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017 |
CRHM CRH Medical | $3.99
| 2/24/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 2/24/2017 |
RX BioSyent | C$11.90
-0.7% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017 |
CPH Cipher Pharmaceuticals | C$13.29
-2.1% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017 |
ABUS Arbutus Biopharma | $3.14
-3.1% | 1/9/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017 |
XENE Xenon Pharmaceuticals | $31.83
-4.3% | 12/22/2016 | Initiated by | Bloom Burton | - | Buy | $14.50 | N/A | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016 |
ABUS Arbutus Biopharma | $3.14
-3.1% | 12/14/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016 |
GUD Knight Therapeutics | C$6.04
-0.2% | 11/10/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016 |
AUPH Aurinia Pharmaceuticals | $7.47
-1.6% | 11/4/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/2/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016 |
CRHM CRH Medical | $3.99
| 10/28/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 10/28/2016 |
ACHV Achieve Life Sciences | $2.07
-5.0% | 5/3/2013 | Target Raised by | Bloom Burton | - | Buy | $4,000.00 -> $5,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013 |
ACHV Achieve Life Sciences | $2.07
-5.0% | 3/8/2013 | Target Raised by | Bloom Burton | - | | $3,600.00 -> $4,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013 |
ONC Oncolytics Biotech | C$1.37
+19.1% | 12/18/2012 | Downgraded by | Bloom Burton | - | Buy -> Hold | | N/A | View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012 |
I was wrong about Trump (Ad) I made a mistake.
A mistake I feel very foolish about.
After speaking with Donald Trump and some of his advisors, I believed him.
I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years.
But I was wrong. Let me show you exactly what we’re doing to prepare. |
THTX Theratechnologies | $3.17
-0.9% | 6/25/2012 | Downgraded by | Bloom Burton | - | Hold -> Sell | $2.50 -> $0.75 | N/A | View details for Bloom Burton rating of Theratechnologies (NASDAQ:THTX) on 6/25/2012 |
ACHV Achieve Life Sciences | $2.07
-5.0% | 5/4/2012 | Target Lowered by | Bloom Burton | - | Buy | $3,800.00 -> $3,600.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012 |
